CXXRX
Price
$25.67
Change
-$0.03 (-0.12%)
Updated
Jul 31 closing price
Net Assets
2.66B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

CXXRX vs VSMAX

CXXRX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CXXRX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CXXRX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. CXXRX (2.66B). VSMAX pays higher dividends than CXXRX: VSMAX (1.21) vs CXXRX (1.04). CXXRX was incepted earlier than VSMAX: CXXRX (14 years) vs VSMAX (26 years). CXXRX (0.20) is less costly to investors than VSMAX (0.05). CXXRX is a more actively managed with annual turnover of: 22.00 vs. VSMAX (17.00). CXXRX has a lower initial minimum investment than VSMAX: CXXRX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. CXXRX (17.80). VSMAX return over 5 years is better than : 35.11 vs. CXXRX (-10.71).
CXXRXVSMAXCXXRX / VSMAX
Total Expense Ratio0.200.05400%
Annual Report Gross Expense Ratio0.200.05400%
Fund Existence14 years26 years-
Gain YTD13.97414.58896%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.66B189B1%
Annual Yield % from dividends1.041.2186%
Returns for 1 year17.8022.5879%
Returns for 3 years6.3343.4215%
Returns for 5 years-10.7135.11-30%
Returns for 10 years26.47155.9617%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H